B. Metzler seel. Sohn & Co. AG Buys Shares of 123,784 CVS Health Corporation $CVS

Key Points

• B. Metzler seel. Sohn & Co. AG acquired 123,784 CVS Health shares during the second quarter, valued at approximately $12.8 million. Institutional investors collectively own 80.66% of CVS shares.
• CVS Health reported stronger-than-expected quarterly results, with $2.58 in earnings per share and $106.1 billion in revenue, up 7.3% year over year. Analysts expect approximately $8.02 in fiscal-year EPS.
• The company pays a quarterly dividend of $0.665 per share, equivalent to a 2.8% annual yield. Wall Street maintains a “Moderate Buy” consensus, with an average price target of $107.17.

B. Metzler seel. Sohn & Co. AG acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 123,784 shares of the pharmacy operator's stock, valued at approximately $12,805,000.

A number of other large investors have also bought and sold shares of CVS. Elevation Wealth Partners LLC boosted its stake in CVS Health by 41.8% in the 2nd quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator's stock worth $37,000 after purchasing an additional 105 shares during the period. Apella Capital LLC increased its position in shares of CVS Health by 1.7% during the second quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator's stock valued at $724,000 after buying an additional 117 shares during the period. CYBER HORNET ETFs LLC lifted its holdings in shares of CVS Health by 4.1% in the third quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator's stock worth $259,000 after buying an additional 134 shares in the last quarter. Northwestern Mutual Investment Management Company LLC boosted its position in shares of CVS Health by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 40,560 shares of the pharmacy operator's stock valued at $3,219,000 after acquiring an additional 136 shares during the period. Finally, CoreCap Advisors LLC grew its stake in CVS Health by 4.2% during the second quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator's stock valued at $360,000 after acquiring an additional 139 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Trading Up 0.2%

NYSE CVS opened at $93.83 on Friday. The stock's 50-day simple moving average is $102.19 and its two-hundred day simple moving average is $88.83. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $120.01 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 0.89 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter in the previous year, the company posted $1.81 EPS. CVS Health's quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health's dividend payout ratio (DPR) is currently 70.37%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on CVS shares. Weiss Ratings upgraded shares of CVS Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 5th. JPMorgan Chase & Co. boosted their price target on shares of CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Cantor Fitzgerald increased their price objective on CVS Health from $100.00 to $110.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 7th. HSBC reissued a "hold" rating and set a $103.00 price objective on shares of CVS Health in a research note on Monday, July 6th. Finally, Wall Street Zen upgraded CVS Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 8th. Twenty-two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source